Abstract
Imatinib has revolutionized the treatment and prognosis of patients with gastrointestinal stromal tumors (GIST). In contrast to liver and/or abdominal involvement, bone metastases are an uncommon event in GIST. We report here two patients with metastatic GIST who developed pelvic bone marrow focal lesions visible on MRI examinations, while Imatinib dramatically improved other tumor sites. A biopsy in one patient diagnosed bone marrow necrosis. The other patient had a favorable follow-up over several years, without bone metastases. Focal bone marrow abnormalities, detected on MRI examinations and mimicking bone metastases in patients who were otherwise responding, should be considered as probable bone marrow necrosis.
Similar content being viewed by others
References
Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11: 728–734.
De Mestier P, Guetz GD. Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics. World J Surg 2005;29: 357–361.
Ray-Coquard J, Le Cesne A, Blay JY. STI571 and gastrointestinal stromal tumors. Bull Cancer 2001;88: 661–662.
Choi H. Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 2005;7: 307–311.
Padhani AR, Ollivier L. The RECIST criteria: implications for diagnostic radiologists. Br J Radiol 2001;74 :983–986.
Vanel D, Albiter M, Shapeero LG, et al. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. Eur J Radiol 2005;54: 118–123.
Matsue K, Takeuchi M, Koseki M, Uryu H. Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Ann Hematol 2006;85: 542–544.
Tamura T, Tasaka T, Fujimoto M, Matsuhashi Y, Fukumot T, Mano S, Kuwajima M, Nagai M. Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy. Haematologica 2004;89:ECR32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vanel, D., Bonvalot, S., Pechoux, C.L. et al. Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastases. Skeletal Radiol 36, 895–898 (2007). https://doi.org/10.1007/s00256-007-0344-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-007-0344-0